Stephen J. Dipalma - Net Worth and Insider Trading
Stephen J. Dipalma Net Worth
The estimated net worth of Stephen J. Dipalma is at least $1,574 dollars as of 2024-11-28. Stephen J. Dipalma is the Interim CFO of Interleukin Genetics Inc and owns about 349,855 shares of Interleukin Genetics Inc (ILIU) stock worth over $1,574. Details can be seen in Stephen J. Dipalma's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen J. Dipalma has not made any transactions after 2016-07-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen J. Dipalma
Stephen J. Dipalma Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen J. Dipalma owns 9 companies in total, including Generation Bio Co (GBIO) , Anchiano Therapeutics Ltd (CMMB) , and Spero Therapeutics Inc (SPRO) among others .
Click here to see the complete history of Stephen J. Dipalma’s form 4 insider trades.
Insider Ownership Summary of Stephen J. Dipalma
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GBIO | Generation Bio Co | 2020-06-11 | See Remarks |
| CMMB | Anchiano Therapeutics Ltd | 2020-05-01 | Chief Financial Officer |
| SPRO | Spero Therapeutics Inc | 2019-11-08 | Interim CFO |
 | | 2016-07-29 | Interim CFO |
| | 2015-03-09 | Interim CFO |
| | 2008-02-14 | CFO and Secretary |
| | 2020-05-01 | Chief Financial Officer |
| | 2021-05-17 | Interim CFO |
| | 2021-01-29 | Interim CFO |
Stephen J. Dipalma Latest Holdings Summary
Stephen J. Dipalma currently owns a total of 1 stock. Stephen J. Dipalma owns 349,855 shares of Interleukin Genetics Inc (ILIU) as of July 29, 2016, with a value of $1,574.
Latest Holdings of Stephen J. Dipalma
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ILIU | Interleukin Genetics Inc | 2016-07-29 | 349,855 | 0.00 | 1,574 |
Holding Weightings of Stephen J. Dipalma
Stephen J. Dipalma Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen J. Dipalma has made a total of 0 transactions in Interleukin Genetics Inc (ILIU) over the past 5 years. The most-recent trade in Interleukin Genetics Inc is the acquisition of 100,603 shares on July 29, 2016, which cost Stephen J. Dipalma around $10,060.
Insider Trading History of Stephen J. Dipalma
- 1
Stephen J. Dipalma Trading Performance
GuruFocus tracks the stock performance after each of Stephen J. Dipalma's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen J. Dipalma is 25%. GuruFocus also compares Stephen J. Dipalma's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen J. Dipalma within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen J. Dipalma's insider trading performs compared to the benchmark.
Performance of Stephen J. Dipalma
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 50 | | | | | |
| Relative Return to S&P 500(%) | 49.69 | | | | | |
Stephen J. Dipalma Ownership Network
Stephen J. Dipalma Owned Company Details
What does Generation Bio Co do?
Who are the key executives at Generation Bio Co?
Stephen J. Dipalma is the See Remarks of Generation Bio Co. Other key executives at Generation Bio Co include CHIEF OPERATING OFFICER Antoinette Paone , CHIEF LEGAL OFFICER Yalonda Howze , and CHIEF STRATEGY OFFICER Phillip Samayoa .
Generation Bio Co (GBIO) Insider Trades Summary
Over the past 18 months, Stephen J. Dipalma made no insider transaction in Generation Bio Co (GBIO). Other recent insider transactions involving Generation Bio Co (GBIO) include a net purchase of 20,000 shares made by Dannielle Appelhans , a net sale of 9,835 shares made by Antoinette Paone , and a net purchase of 342,960 shares made by Rowland Charles A Jr .
In summary, during the past 3 months, insiders sold 0 shares of Generation Bio Co (GBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,835 shares of Generation Bio Co (GBIO) were sold and 551,455 shares were bought by its insiders, resulting in a net purchase of 541,620 shares.
Generation Bio Co (GBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Generation Bio Co Insider Transactions
Stephen J. Dipalma Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen J. Dipalma. You might contact Stephen J. Dipalma via mailing address: C/o Spero Therapeutics, Inc., 675 Massachusetts Avenue, 14th Floor, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
